References
- Penno MA, Couper JJ, Craig ME, et al. Environmental Determinants of Islet Autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr. 2013;13(1):1–12.
- Krischer JP, Liu X, Lernmark Å, et al. Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study. Diabetes Care. 2022;45(10):2271–2281.
- Rewers M, Bugawan T, Norris J, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807–812.
- Group TS. The environmental determinants of diabetes in the young (TEDDY) study. Ann N Y Acad Sci. 2008;1150(1):1–13.
- Peet A, Kool P, Ilonen J, et al. Birth weight in newborn infants with different diabetes-associated HLA genotypes in three neighbouring countries: Finland, Estonia and Russian Karelia. Diabetes Metab Res Rev. 2012;28(5):455–461.
- Ziegler A-G, Hummel M, Schenker M, et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes. 1999;48(3):460–468.
- Gillman MW. Developmental origins of health and disease. N Engl J Med. 2005;353(17):1848–1850.
- Alcazar O, Hernandez LF, Nakayasu ES, et al. Parallel multi-omics in high-risk subjects for the identification of integrated biomarker signatures of type 1 diabetes. Biomolecules. 2021;11(3):383.
- Li Q, Parikh H, Butterworth MD, et al. Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY study. Diabetes. 2020;69(3):465–476.
- Lamichhane S, Ahonen L, Dyrlund TS, et al. Dynamics of plasma lipidome in progression to islet autoimmunity and type 1 diabetes–type 1 diabetes prediction and prevention study (DIPP). Sci Rep. 2018;8(1):10635.
- Prentice RL. On the design of synthetic case-control studies. Biometrics. 1986;42(2):301–310.
- Richardson D. An incidence density sampling program for nested case-control analyses. Occup Environ Med. 2004;61(12):e59.
- Borgan Ø, Keogh R. Nested case–control studies: should one break the matching? Lifetime Data Anal. 2015;21(4):517–541.
- Breslow NE. Statistics in epidemiology: the case-control study. J Am Stat Assoc. 1996;91(433):14–28.
- Goldstein L, Langholz B. Asymptotic theory for nested case-control sampling in the cox regression model. Ann Statist. 1992;20(4):1903–1928.
- Ngo LH, Inouye SK, Jones RN, et al. Methodologic considerations in the design and analysis of nested case-control studies: association between cytokines and postoperative delirium. BMC Med Res Methodol. 2017;17(1):1–10.
- McGorm KJ, Brown JD, Thomson RL, et al. A long-term evaluation of Facebook for recruitment and retention in the ENDIA type 1 diabetes pregnancy-birth cohort study. J Diabet Sci Technol. 2022:19322968221079867.
- Dupont WD. Power calculations for matched case-control studies. Biometrics. 1988;44(4):1157–1168.
- R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020.
- Stevenson M, Sergeant E. epiR: tools for the analysis of epidemiological data. 2022. R package version 2.0.48. https://CRAN.R-project.org/package=epiR
- Guo Y, Logan HL, Glueck DH, et al. Selecting a sample size for studies with repeated measures. BMC Med Res Methodol. 2013;13(1):1–8.
- Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. J Am Med Assoc. 2013;309(23):2473–2479.
- Orban T, Sosenko JM, Cuthbertson D, et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial–type 1. Diabetes Care. 2009;32(12):2269–2274.
- Dahlquist GG, Nyström L, Patterson CC. Incidence of type 1 diabetes in Sweden among individuals aged 0–34 years, 1983–2007: an analysis of time trends. Diabetes Care. 2011;34(8):1754–1759.
- Maahs DM, West NA, Lawrence JM, et al. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481–497.
- Lee HS, Burkhardt BR, McLeod W, et al. Biomarker discovery study design for type 1 diabetes in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Metab Res Rev. 2014;30(5):424–434.
- Yeung W-CG, Al-Shabeeb A, Pang CNI, et al. Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes. 2012;61(6):1500–1508.
- Vehik K, Lynch KF, Wong MC, et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med. 2019;25(12):1865–1872.
- Lin IF, Paik MC. Matched case—control data analysis with selection bias. Biometrics. 2001;57(4):1106–1112.
- Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440–9445.
- Lee HS, Lynch KF, Krischer JP. Nested case-control data analysis using weighted conditional logistic regression in the environmental determinants of diabetes in the young (TEDDY) study: a novel approach. Diabetes Metab Res Rev. 2020;36(1):e3204.
- Ruiz-Perez D, Guan H, Madhivanan P, et al. So you think you can PLS-DA? BMC Bioinf. 2020;21(Suppl 1):2.
- Balzano-Nogueira L, Ramirez R, Zamkovaya T, et al. Integrative analyses of TEDDY omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes. Genome Biol. 2021;22(1):1–27.